SCHEMBL17994355

SCHEMBL17994355

CCc1nc2cccc3c2n1-c1ccccc1O3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 2/20 0.40
PDE4B Q07343 4/20 0.38
P2RX4 Q99571 2/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
PIK3CD O00329 1/20 0.35
RECQL P46063 1/20 0.35
P2RX1 P51575 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
PDE2A O00408 1/20 0.35
PDE6D O43924 1/20 0.35
PDE8A O60658 1/20 0.35
PDE5A O76074 1/20 0.35
PDE9A O76083 1/20 0.35
PDE8B O95263 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17994637 0.85 GAA (0.37) L3MBTL1
SCHEMBL17994469 0.85 GAA (0.37) L3MBTL1
SCHEMBL17994848 0.84 PDE4B (0.39) L3MBTL1ALDH1A1PDE4BMAPTTSHR
SCHEMBL17994842 0.84 PDE4B (0.39) L3MBTL1ALDH1A1PDE4BMEN1MAPT
SCHEMBL17994315 0.83 TSHR (0.45) L3MBTL1ALDH1A1PDE4BP2RX4PIK3CD
SCHEMBL17994455 0.83
SCHEMBL17994646 0.83 CYP1A2 (0.34) L3MBTL1ALDH1A1PDE4BHPGDPIK3CD
SCHEMBL17994642 0.83 GAA (0.36) L3MBTL1
SCHEMBL17994655 0.83 HDAC1 (0.40) L3MBTL1ALDH1A1KDM4EMEN1MAPT
SCHEMBL17994478 0.83 CYP1A2 (0.34) L3MBTL1ALDH1A1PDE4BHPGDPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10263193-B2 Heterocyclic compound and organic light-emitting element using same LG CHEM, LTD. (KR) 2019-04-16 US disclosed
US-20160233431-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME LG CHEM, LTD. (KR) 2016-08-11 US disclosed
US-20160233431-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME LG CHEM, LTD. (KR) 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10263193-B2 Heterocyclic compound and organic light-emitting element using same CRY1, NFE2L2, CRY2 L3MBTL1 3217/4885ALDH1A1 73/4885PDE4B 4530/4885
US-20160233431-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME CRY1, CRY2, NR2E3 L3MBTL1 854/4885ALDH1A1 252/4885PDE4B 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.